Genalyte
Latest round
- Series C
Last raised
- Mar 2023
Total raised
- $161M
Investors
- 10
About Genalyte
Genalyte, Inc.Founded in 2007 and headquartered in San Diego, US, Genalyte, Inc. is focused on transforming laboratory testing with its advanced technology. Cary Gunn, the founder, has a history of entrepreneurial ventures, although specific details about his previous companies are not disclosed.Genalyte's core product, the Merlin device, revolutionizes on-site blood testing by combining multiple laboratory functions into a single, self-operating unit. This technology enables rapid testing for chemistry and hematology, as well as the proprietary Maverick Immunoassay Analyser, delivering results in under 30 minutes. The primary end users of Merlin include healthcare providers such as primary care physicians and hospitals, who often encounter challenges with traditional lab testing, including delays and communication failures regarding patient results. By integrating seamlessly into existing workflows and electronic medical record (EMR) systems, Merlin addresses critical issues like pre-analytical errors and manual data entry mistakes, thereby improving patient care.Genalyte's revenue model centers around business-to-business (B2B) transactions with healthcare providers and institutions, focusing on the sale and deployment of the Merlin device and associated services. The company engages in direct sales to hospitals and clinics, facilitated through partnerships that streamline the integration of their technology into existing healthcare systems. Transactions involve service agreements for ongoing technical support and maintenance of the Merlin devices. The company is focused on expanding its product offerings and enhancing its technology to meet the evolving needs of healthcare providers. Genalyte aims to enter new markets, although specific targeted regions have not been disclosed.
Who invested in Genalyte
10 investors across 6 rounds
See all investors in Genalyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genalyte
Who invested in Genalyte?
Genalyte has 10 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genalyte raised?
Genalyte has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Genalyte last raise money?
Genalyte's most recent round on record is a Series C, in Mar 2023.
What does Genalyte do?
Genalyte is a healthcare it company.
Where is Genalyte headquartered?
Genalyte is headquartered in San Diego, US.
Which VCs invest in companies like Genalyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Genalyte's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Genalyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.